|
|
Article: Purdue Pharma L.P. Announces Signing of Consent Judgment Ending OxyContin(R) Tablets Patent Lawsuit with Teva Pharmaceuticals.
- Article from:
- PR Newswire
- Article date:
- October 16, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Teva admits Purdue Pharma's OxyContin patents are valid, enforceable and infringed
STAMFORD, Conn., Oct. 16 /PRNewswire/ -- The patent litigation between Purdue Pharma L.P. of Stamford, Connecticut and Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania concerning certain Purdue Pharma patents on OxyContin(R) (oxycodone HCl controlled-release) Tablets ended on Thursday, October 12 with the signing of a Consent Judgment
in the United States District Court for the Southern District of New York. In the Consent Judgment, Teva admits that Purdue Pharma's OxyContin patents are valid, enforceable and infringed by Teva's extended-release oxycodone ...